Patent · US Active

Immunoregulatory agents

US9643972B2 · kind B2 · utility

8Cited by

4References

47Claims

0Family size

Assignee

Flexus Biosciences, Inc. · US

Inventors

Hilary Plake Beck · Emerald Hills, US
Juan C. Jaen · Plymouth, US
Maksim Osipov · Belmont, US
Jay P. Powers · Pacifica, US
Maureen Kay Reilly · Burlingame, US
Hunter Paul Shunatona · Oakland, US
James Ross Walker · Menlo Park, US
Mikhail Zibinsky · Redwood City, US
James Aaron Balog · Lambertville, US
David K. Williams · Cinnaminson, US
Jay A. Markwalder · New London, US
Emily Charlotte Cherney · Newtown, US
Weifang Shan · Princeton, US
Audris Huang · Princeton, US

Key dates

Filing date	Nov 5, 2015
Grant date	May 9, 2017
Priority date	—
Expiry date	Nov 5, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2300/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compounds that modulate the oxidoreductase enzyme indoleamine 2,3-dioxygenase, and compositions containing the compounds, are described herein. The use of such compounds and compositions for the treatment and/or prevention of a diverse array of diseases, disorders and conditions, including cancer- and immune-related disorders, that are mediated by indoleamine 2,3-dioxygenase is also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.